spacer
home > epc > spring 2002 > the importance of market research in patient recruitmen
PUBLICATIONS
European Pharmaceutical Contractor

The Importance of Market Research in Patient Recruitmen

Patient recruitment and enrolment are destined to become more challenging as the number of clinical studies grows. There are presently an estimated 50,000 to 60,000 ongoing clinical trials in the US alone (1), and there is every reason to expect this figure to increase based on the rise in R&D expenditures; the number of compounds in the pipeline; the growing number of patients per new drug application (NDA); and the more complex and global nature of trials. Growth is likely to be accompanied by a rise in directly competitive clinical trials, with many seeking access to the same investigators. In addition, there are bound to be more studies aimed at testing new compounds in special populations, which will yield a marketing advantage to the innovator if the studies prove successful.

The traditional patient recruitment model has centred around sponsors' reliance on proven investigators who promise to recruit the agreed upon number of patients from their own resources. In the past, this approach was generally successful as there were far fewer trials than there are presently. Today, a sought-after investigator is likely to have already used an in-house patient database to enrol several ongoing competitive trials, so that investigator may have exhausted his or her supply of potentially qualified patients for new trials. This reality is reflected in the fact that 78 per cent of today's clinical trials fail to meet patient enrolment deadlines (2).


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Diana Anderson, PhD, President & Chief Executive Officer at Rheumatology Research International

Dr Diana Anderson is President and Chief Executive Officer at Rheumatology Research International, a comprehensive rheumatology provider to the clinical trials industry, based in Dallas, Texas. Diana oversees the clinical trial management services of over 50 affiliated private practice and academic investigator sites across the US and Canada.

She is well published in the area of arthritis and patient recruitment and is the author of two books: 50 Ways to Cope with Arthritis and A Guide to Patient Recruitment: Today's Best Practices and Proven Strategies. She is a Consultant in these areas to the pharmaceutical industry and performs numerous lectures in the areas of SMOs and patient recruitment.

spacer
Dr Diana Anderson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Gerresheimer manufactures sustainable primary plastic packaging

Düsseldorf, January 14, 2020. Consumers are placing great importance on eco-friendly plastic packaging products, specifically – and increasingly – on sustainable packaging solutions that can be disposed of in an environmentally friendly way. At Gerresheimer, therefore, innovation and environmental protection go hand in hand. A pioneer in the quest for greater sustainability, Gerresheimer offers an extensive standard range of plastic packaging and devices customized solutions made from PET, R-PET, and BIO-PET plastics.
More info >>

White Papers

Comparator Sourcing in Oncology Trials

Clinical Services International

This is an exciting time for oncology trials, year on year record numbers of therapeutics are launched and the indications for many drugs on the market are increasing rapidly. Immunotherapies and next generation biotherapeutics are being approved for more tumour types and a growing percentage of the late stage oncology pipeline are targeted biologics.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement